Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia.
about
Mass spectrometry-based proteomics for pre-eclampsia and preterm birthMetabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.Marked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications.Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry.Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: a strategy to distinguish patients with preeclampsia from matching control individuals.Characterization of discriminatory urinary proteomic biomarkers for severe preeclampsia using SELDI-TOF mass spectrometry.Proteomic biomarkers in second trimester amniotic fluid that identify women who are destined to develop preeclampsia.A mass spectrometric multicenter study supports classification of preeclampsia as heterogeneous disorder.Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration.Proteomics in obstetrics and gynecologyUtility of proteomics in obstetric disorders: a review.Global approach to perinatal medicine: functional genomics and proteomics.Maternal serum proteome changes between the first and third trimester of pregnancy in rural southern Nepal.Genetic dissection of platelet function in health and disease using systems biology.Proteomic technologies for prenatal diagnostics: advances and challenges ahead.Novel approaches for mechanistic understanding and predicting preeclampsia.Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biomarker discovery.Proteomics in hypertension.Clinical proteomics in obstetrics and neonatology.Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus--harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis.Amniotic fluid clusterin in pregnancies complicated by the preterm prelabor rupture of membranes.Complement component C4A and apolipoprotein A-I in plasmas as biomarkers of the severe, early-onset preeclampsia.Nested case-control study reveals increased levels of urinary proteins from human kidney toxicity panels in women predicted to develop preeclampsia.Identification of interleukin-1 beta, but no other inflammatory proteins, as an early onset pre-eclampsia biomarker in first trimester serum by bead-based multiplexed immunoassays.An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia.Circulating Clusterin and Osteopontin Levels in Asthma and Asthmatic Pregnancy.Aberrant processing of plasma vitronectin and high-molecular-weight kininogen precedes the onset of preeclampsia.Preeclamptic toxemia: a disease ripe for proteomic discovery.PROTEOMICS APPROACHES IN PRE-ECLAMPSIA RESEARCHIntegrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia
P2860
Q28083761-2F08C1E9-CEF1-4D6A-BE94-B583D7725CBBQ30524877-457083B1-0191-4C36-9DC2-BDDA9A4C6FCAQ33309151-4F19E02D-D2C2-4ADE-93C7-97B6392E8BEEQ33346764-9012EC65-EDB5-49C6-B8BE-07BD5C8079AAQ33527649-165E600A-5213-4606-AEDF-EF717AC8175EQ33894249-8C759413-6D3E-4BF9-90EC-7825D2EEEF62Q34245904-FA86D2E1-DC3D-4CE9-AB57-911AE6AFAA1BQ34267851-85848E40-5223-428C-8664-553233B2F75DQ34673147-A31921F1-F19F-4925-80BF-8B7B854DF607Q35130974-7C1A71A8-47B5-42BD-9FE0-8BD62D2C42D2Q35491359-D96A138C-1FE9-44BD-AD5A-ED31BF93A696Q36102697-E09AEEB5-CAA1-47F8-9C38-A6634FEF73AAQ36435662-A55D2732-EF6D-443E-A3D1-BA590CBC1957Q37156517-2E4929E5-3209-4A7F-9282-AE7DCB6C32A0Q37390676-74F4A76B-E84C-4631-9871-8F5B524412E2Q37465594-BBAD5AE2-06C7-426B-83BE-348681FDF084Q37996960-D21921DB-6A2E-49BC-A1A4-61334FC7B33EQ38033006-89AD3691-E85C-47D6-ABE0-4AA61E0AADF6Q38176934-F92BE9B0-61BA-4D0B-BA8F-E95898987155Q38592484-281A1D73-E91C-4C5B-A5C8-A7AB2A773E7BQ39223197-73506654-8D81-4556-9D83-3AC6CE9F78E8Q39523701-23A6AE1D-72C7-4F42-9B4A-5A557C51635AQ40603208-A7BAE2BA-B1D4-4ECC-820E-DDA9CE662D23Q42251202-208C8F42-1842-4DE9-9C9F-4421BC7F9FFAQ46412308-5C670DF6-2330-4D5E-B3C6-2525DEAE8A08Q47145218-97870B10-DE2E-4E5A-BCA1-6E624F40CBDDQ47175696-7FB6A410-D23A-447F-8727-BE18330ABCDDQ47963729-B1EEECF5-3DC8-4176-AA70-591A109CC9D2Q58035975-2C299270-65E8-44ED-AFDF-D843134CBB95Q58795465-E075DD88-5B7D-4729-B0E7-50B2AA34C6B9
P2860
Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Proteome analysis reveals elev ...... in patients with preeclampsia.
@ast
Proteome analysis reveals elev ...... in patients with preeclampsia.
@en
type
label
Proteome analysis reveals elev ...... in patients with preeclampsia.
@ast
Proteome analysis reveals elev ...... in patients with preeclampsia.
@en
prefLabel
Proteome analysis reveals elev ...... in patients with preeclampsia.
@ast
Proteome analysis reveals elev ...... in patients with preeclampsia.
@en
P2093
P356
P1433
P1476
Proteome analysis reveals elev ...... in patients with preeclampsia.
@en
P2093
Hideki Watanabe
Hiromi Hamada
Hiroyuki Yoshikawa
Kimiko Yamakawa-Kobayashi
Naoki Yamada
Satoshi Sohda
Tadao Arinami
P304
P356
10.1002/PMIC.200300565
P577
2004-02-01T00:00:00Z